Linio Biotech

Linio Biotech is a biotechnology platform company based in Helsinki, Finland, founded in 2017.

The company specializes in regenerative medicine and aesthetics, focusing on innovative solutions for skin regeneration and treatment. Its mission is to advance regenerative aesthetics by developing products that restore both form and function, inspired by the idea of enabling defective skin to heal itself. The primary product offered by Linio Biotech is Tience®, recognized as the world's first cell-free tissue product for tissue regeneration. Tience is a sterile, ready-to-use injectable that stimulates the body's natural healing processes for various skin conditions, including severe scars, skin defects, aging skin, and vascular-related cutaneous issues. The company operates in-house tissue establishment laboratories for manufacturing and is supported by a team of scientists and external partners. Linio Biotech targets the medical aesthetics sector, addressing significant needs in skin treatment and regeneration.